%D9%84%D9%88%D8%B1%D8%A7%D8%B3%D9%8A%D8%AF%D9%88%D9%86Category:LurasidoneLurasidonLurasidoneLurasidone%E3%83%AB%E3%83%A9%E3%82%B7%E3%83%89%E3%83%B3Lurasidonum%E0%AC%B2%E0%AD%81%E0%AC%B0%E0%AC%BE%E0%AC%B8%E0%AC%BF%E0%AC%A1%E0%AC%A8Lurazydon%D0%9B%D1%83%D1%80%D0%B0%D0%B7%D0%B8%D0%B4%D0%BE%D0%BDLurasidonLurasidonLurasidonLurasidoneQ416992
about
P1056
P3781
Update on the development of lurasidone as a treatment for patients with acute schizophreniaPrevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist.Lurasidone: an atypical antipsychotic for schizophrenia.Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.Iloperidone, asenapine and lurasidone: a primer on their current status.Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.Lurasidone: a new drug in development for schizophrenia.The novel antipsychotic drug lurasidone enhances N-methyl-D-aspartate receptor-mediated synaptic responses.Critical appraisal of lurasidone in the management of schizophrenia.Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study.Lurasidone: a clinical overview.Interactions between antiepileptics and second-generation antipsychotics.Lurasidone for schizophrenia: what's different?Lurasidone (latuda®): an atypical antipsychotic.Lurasidone in schizophrenia: new information about dosage and place in therapy.Evaluation of dopamine D₂/D₃ and serotonin 5-HT₂A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography.Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study.5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.Pharmacokinetics of lurasidone, a novel atypical anti-psychotic drug, in rats.The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats.Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stressStructural insight into receptor-selectivity for lurasidone
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Lurasidon
@de
Lurasidon
@sh
Lurasidon
@sr
Lurasidon
@sv
Lurasidone
@vi
Lurasidonum
@la
lurasidon
@nn
lurasidone
@en
lurasidone
@fr
lurazydon
@pl
type
label
Lurasidon
@de
Lurasidon
@sh
Lurasidon
@sr
Lurasidon
@sv
Lurasidone
@vi
Lurasidonum
@la
lurasidon
@nn
lurasidone
@en
lurasidone
@fr
lurazydon
@pl
altLabel
C28H36N4O2S
@fr
Latuda®
@en
Lurasidona
@en
Lurasidone
@en
Lurasidonum
@en
SM-13496
@en
ラツーダ
@ja
prefLabel
Lurasidon
@de
Lurasidon
@sh
Lurasidon
@sr
Lurasidon
@sv
Lurasidone
@vi
Lurasidonum
@la
lurasidon
@nn
lurasidone
@en
lurasidone
@fr
lurazydon
@pl